Topics

Explore topics

#theragenomics

Follow to get notified about new posts with this tag
gut50
theragenomics
7y
Febuxostat (Uloric) and its problem with cardiovascular mortality
Febuxostat (Uloric) and its problem with cardiovascular mortality
Despite drug safety problems of cardiovascular mortality with Febuxostat (Uloric), the benefits might still be seen to outweigh risks for selected gout patients. This notion may become more and more disputed,
1
2
gut50
theragenomics
7y
Grossesse et risques de malformations: Il n'y a pas seulement le valproate
Grossesse et risques de malformations: Il n'y a pas seulement le valproate
may 01, 2019 - En France, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) viens de publier une analyse des données disponibles sur le risque de malformations et de troubles
4
1
gut50
theragenomics
7y
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients Alemtuzumab (Lemtrada) is used in the treatment of multiple sclerosis (MS). Moreover, Alemtuzumab, under the Tradenames of Campt,

Discover communities

Explore communities
Create your community